Feasibility Assessment of Implementing a Care System to PREVENT Iatrogenic Dependency (ID)

Not Applicable

Recruiting

• Conditions: Aged
• Interventions: Other: Routine care; Other: Care system to prevent ID

• Registration Number: NCT06173154
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

To assess the feasibility of a care system to prevent iatrogenic dependency during hospitalisation in people 70 years old and over. 2 cares units participate : one with routine care and the other with a care system to prevent ID. The caregivers of this unit receive training about iatrogenic dependency and how prevent it. They set up this prevention and the research compare evolution of dependence hospitalized patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-12-07
• Study First Submitted QC: 2023-12-07
• Study First Posted: 2023-12-15
• Study Start: 2024-06-12
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-07
• Last Update Posted: 2025-04-10
• Primary Completion: 2025-06-30
• Study Completion: 2025-06-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control unit	Routine care	One healthcare unit will implement the healthcare system for the prevention of iatrogenic dependency (ID) and one healthcare unit will provide standard care without any specific system in place.
ID prevention unit	Care system to prevent ID	One healthcare unit will implement the healthcare system for the prevention of iatrogenic dependency (ID) and one healthcare unit will provide standard care without any specific system in place.

Primary Outcome Measures

Name	Time	Method
number of participants with loss of independence	15 days	loss of independence is defined as a decrease of at least 0.5 points in Activities of Daily Living (ADL) scale between admission and discharge of the patient within 15 days of admission to the ward, regardless of when this event occurs during the hospitalization.

Trial Locations

Locations (1)

CHU de Toulouse; 🇫🇷 Toulouse, France